October 2017 - Volume 27 - Issue 5
pp: 403-525


Basic research


Translational research


A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma

Tarhini, Ahmad A.; Floros, Theofanis; Lin, Hui-Min; More

Melanoma Research. 27(5):429-438, October 2017.

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study

Guadagni, Stefano; Fiorentini, Giammaria; Clementi, Marco; More

Melanoma Research. 27(5):439-447, October 2017.

Prognostic significance of cyclooxygenase 2 and phosphorylated Akt1 overexpression in primary nonmetastatic and metastatic cutaneous melanomas

Soares, Ciro D.; Borges, Camilla F.; Sena-Filho, Marcondes; More

Melanoma Research. 27(5):448-456, October 2017.

Clinical research


Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis

Gardner, Laura J.; Ward, Morgan; Andtbacka, Robert H.I.; More

Melanoma Research. 27(5):477-484, October 2017.

Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination

Aboudaram, Amélie; Modesto, Anouchka; Chaltiel, Léonor; More

Melanoma Research. 27(5):485-491, October 2017.

Epidemiology of melanoma



Response to targeted therapy in two patients with metastatic melanoma carrying rare BRAF exon 15 mutations: A598_T599insV and V600_K601delinsE

Rogiers, Aljosja; Borght, Sara Vander; Tuand, Krizia; More

Melanoma Research. 27(5):507-510, October 2017.

Focal necrotizing myopathy with ‘dropped-head syndrome’ induced by cobimetinib in metastatic melanoma

Gauci, Marie-Léa; Laly, Pauline; Leonard-Louis, Sarah; More

Melanoma Research. 27(5):511-515, October 2017.